Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...
Type IV Collagen of Basal Lamina01:05

Type IV Collagen of Basal Lamina

Type IV collagen is a 400 nm long, network-forming collagen that acts as a barrier between the epithelial and endothelial cells. Type IV collagen  forms the backbone of the basement membrane by scaffolding with laminin, entactin, proteoglycans, and fibronectin. Apart from rendering structural support to the basement membrane, it also helps entail signaling potentials necessary for both pathological and physiological functions.
A type IV collagen molecule has six alpha chains which can exist in...
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The disease course is marked...
Inflammatory Bowel Disease I: Introduction01:26

Inflammatory Bowel Disease I: Introduction

Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Justification for the use of a FODMAP diet in patients with irritable bowel syndrome: focus on small intestinal disaccharidase activity].

Terapevticheskii arkhiv·2026
Same author

[A new paradigm of the pathogenesis of primary sclerosing cholangitis associated with ulcerative colitis: microbiota and system intestine-liver. A review].

Terapevticheskii arkhiv·2026
Same author

[Radiation-induced intestinal injury].

Terapevticheskii arkhiv·2025
Same author

[Results of non-medical switching from original infliximab to its Russian biosimilar in patients with ulcerative colitis].

Terapevticheskii arkhiv·2025
Same author

[Chronic small bowel obstruction in a patient with post-radiation enteropathy. Case report].

Terapevticheskii arkhiv·2025
Same author

[Russian Cross-disciplinary Consensus on the diagnosis and treatment of spondyloarthritis associated with inflammatory bowel diseases].

Terapevticheskii arkhiv·2025

Related Experiment Video

Updated: Jul 6, 2026

Murine Colitis Modeling using Dextran Sulfate Sodium (DSS)
08:39

Murine Colitis Modeling using Dextran Sulfate Sodium (DSS)

Published on: January 19, 2010

[Cholagenic diarrhea].

A I Parfenov, L M Krums, A E Lychkova

    Terapevticheskii Arkhiv
    |April 1, 2008
    PubMed
    Summary

    Cholagenic diarrhea, characterized by bile acid malabsorption, occurs after small intestine resection or gallbladder removal. Treatment involves bile acid sequestrants or gallbladder stimulants.

    Area of Science:

    • Gastroenterology
    • Digestive Diseases
    • Bile Acid Metabolism

    Background:

    • Cholagenic diarrhea (CD) is a significant cause of chronic diarrhea.
    • Understanding its specific etiological and pathophysiological mechanisms is crucial for effective management.

    Purpose of the Study:

    • To define cholagenic diarrhea as a distinct nosological entity.
    • To characterize its etiology, pathogenesis, clinical presentation, and treatment strategies.

    Main Methods:

    • 167 patients with chronic diarrhea were evaluated.
    • Methods included duodenal intubation for cholic acid estimation, fecal analysis (mass, fat, electrolytes), and assessment of gallbladder and intestinal electromotor activity (EMA).
    • Specific patient groups included those with small intestine resection, cholecystectomy, celiac disease, and biliary dyskinesia.

    More Related Videos

    Chronic Salmonella Infection Induced Intestinal Fibrosis
    08:40

    Chronic Salmonella Infection Induced Intestinal Fibrosis

    Published on: September 22, 2019

    An Improved Method for the Preparation of Type I Collagen From Skin
    05:17

    An Improved Method for the Preparation of Type I Collagen From Skin

    Published on: January 21, 2014

    Related Experiment Videos

    Last Updated: Jul 6, 2026

    Murine Colitis Modeling using Dextran Sulfate Sodium (DSS)
    08:39

    Murine Colitis Modeling using Dextran Sulfate Sodium (DSS)

    Published on: January 19, 2010

    Chronic Salmonella Infection Induced Intestinal Fibrosis
    08:40

    Chronic Salmonella Infection Induced Intestinal Fibrosis

    Published on: September 22, 2019

    An Improved Method for the Preparation of Type I Collagen From Skin
    05:17

    An Improved Method for the Preparation of Type I Collagen From Skin

    Published on: January 21, 2014

    Main Results:

    • Extensive small intestine resection led to significantly reduced cholic acid levels in bile.
    • Post-cholecystectomy patients exhibited abnormal colon EMA, indicative of hypermotor dyskinesia.
    • Celiac disease patients showed altered bile acid secretion patterns.

    Conclusions:

    • Cholagenic diarrhea arises from extensive resection, inflammatory ileal diseases, gallbladder hypofunction, and post-cholecystectomy states.
    • CD post-cholecystectomy may be a variant of post-cholecystectomy syndrome.
    • Treatment should target excessive bile acids or stimulate gallbladder contractility as needed.